[Cell mediated immunoresponsiveness in patients with bladder cancer: study using age matched control and multiple dose specific mitogens (author's transl)].
D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation / Q000187:drug effects; D008875:Middle Aged; D008934:Mitogens / Q000008:administration & dosage*; D001749:Urinary Bladder Neoplasms / Q000276:immunology*
D008934:Mitogens